These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8609943)

  • 1. Ephedrine in the treatment of congenital myasthenic syndrome.
    Felice KJ; Relva GM
    Muscle Nerve; 1996 Jun; 19(6):799-800. PubMed ID: 8609943
    [No Abstract]   [Full Text] [Related]  

  • 2. The potential use of ephedrine in Lambert-Eaton myasthenic syndrome : clinical and electrophysiological evaluation.
    Cereda C; Kuntzer T
    J Neurol; 2008 Aug; 255(8):1259-60. PubMed ID: 18535871
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diagnosis and therapy of congenital myasthenia syndrome].
    Sieb JP
    Dtsch Med Wochenschr; 1999 Jan; 124(1-2):24-9. PubMed ID: 9951456
    [No Abstract]   [Full Text] [Related]  

  • 4. Ephedrine for myasthenia gravis, neonatal myasthenia and the congenital myasthenic syndromes.
    Vrinten C; van der Zwaag AM; Weinreich SS; Scholten RJ; Verschuuren JJ
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010028. PubMed ID: 25515947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ephedrine as add-on therapy for patients with myasthenia gravis: protocol for a series of randomised, placebo-controlled n-of-1 trials.
    Vrinten C; Lipka AF; van Zwet EW; Schimmel KJ; Cornel MC; Kuijpers MR; Hekster YA; Weinreich SS; Verschuuren JJ
    BMJ Open; 2015 Jul; 5(7):e007863. PubMed ID: 26185179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lambert Eaton myasthenic syndrome.
    Petty R
    Pract Neurol; 2007 Aug; 7(4):265-7. PubMed ID: 17636143
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of ephedrine on muscle weakness in a model of myasthenia gravis in rats.
    Molenaar PC; Biewenga JE; Van Kempen GT; De Priester JA
    Neuropharmacology; 1993 Apr; 32(4):373-6. PubMed ID: 8497338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromuscular diseases - recent articles from the neuromuscular literature.
    Kelly JJ
    Rev Neurol Dis; 2007; 4(3):173-6. PubMed ID: 17943074
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuromuscular disorders in pregnancy.
    Sax TW; Rosenbaum RB
    Muscle Nerve; 2006 Nov; 34(5):559-71. PubMed ID: 16969835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinidine sulfate therapy for the slow-channel congenital myasthenic syndrome.
    Harper CM; Engel AG
    Ann Neurol; 1998 Apr; 43(4):480-4. PubMed ID: 9546329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theophylline compounds and myasthenia gravis. I. In vitro studies.
    Jacobs R; Karczmar AG; Brumlik J
    Clin Pharmacol Ther; 1973; 14(3):374-9. PubMed ID: 4698565
    [No Abstract]   [Full Text] [Related]  

  • 12. Unusual myasthenic state in a teen-age boy.
    Dahl DS; Sato S
    Neurology; 1974 Sep; 24(9):897-901. PubMed ID: 4859581
    [No Abstract]   [Full Text] [Related]  

  • 13. [The use of intravenous immunglobulin in the treatment of autoimmune neuromuscular diseases].
    Molnár MJ
    Ideggyogy Sz; 2006 Mar; 59(3-4):98-106. PubMed ID: 16634454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "All but death, can be adjusted". Ma Huang (ephedrine) adversities.
    Mack RB
    N C Med J; 1997; 58(1):68-70. PubMed ID: 9019118
    [No Abstract]   [Full Text] [Related]  

  • 15. Electromyography (EMG) accuracy compared to muscle biopsy in childhood.
    Rabie M; Jossiphov J; Nevo Y
    J Child Neurol; 2007 Jul; 22(7):803-8. PubMed ID: 17715269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody.
    Punga AR; Flink R; Askmark H; Stålberg EV
    Muscle Nerve; 2006 Jul; 34(1):111-5. PubMed ID: 16453324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of Acrinor on various functions of the cardiovascular system and lungs].
    Jedlicka K; Krofta K; Nikodýmová L
    Cas Lek Cesk; 1973 Jan; 112(3):80-3. PubMed ID: 4405272
    [No Abstract]   [Full Text] [Related]  

  • 18. [The therapy of the asthmatic patient with Par-Isalon].
    Mathey HG
    Landarzt; 1966 Feb; 42(5):217-9. PubMed ID: 4382465
    [No Abstract]   [Full Text] [Related]  

  • 19. Intra-familial variation in clinical manifestations and response to ephedrine in siblings with congenital myasthenic syndrome caused by novel COLQ mutations.
    Yeung WL; Lam CW; Ng PC
    Dev Med Child Neurol; 2010 Oct; 52(10):e243-4. PubMed ID: 20370815
    [No Abstract]   [Full Text] [Related]  

  • 20. A dominantly inherited syndrome with continuous motor neuron discharges.
    Ashizawa T; Butler IJ; Harati Y; Roongta SM
    Ann Neurol; 1983 Mar; 13(3):285-90. PubMed ID: 6847141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.